FINE N SCOTT

Average Profitability
<0.0001%
Insider Buys Quantity
17
Insider Buys Sum
$1.27M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of FINE N SCOTT

The largest purchase of all time was on 2014-02-19 and amounted to 4500000 shares of Cyclo Therapeutics, Inc. for $225,000.

Biography of FINE N SCOTT

No biography is available at this moment.

2023-04-20PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
299,402
2.7233%
$0.71$212,575+105.99%
2022-02-07PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
10,334
0.1229%
$3.58$36,996-41.9%
2022-01-19PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
5,000
0.0572%
$3.89$19,450-47.28%
2021-12-15PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
5,000
0.0758%
$3.89$19,450-45.04%
2021-12-02PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
5,000
0.0775%
$4.93$24,650-54.81%
2021-11-19PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
5,000
0.0782%
$5.25$26,250-56.36%
2021-09-15PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
5,000
0.0756%
$6.35$31,750-52.77%
2020-12-11PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
20,000
1.4924%
$5.00$100,000+74.7%
2020-08-27PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
500,000
0.2887%
$0.10$50,000-23.41%
2020-04-24PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
730,030
0.3142%
$0.10$73,003-29.41%
2019-09-18PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
10,000
0.008%
$0.17$1,7500%
2019-07-31PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
50,000
0.0449%
$0.25$12,500-17.39%
2019-05-31PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
400,000
0.22%
$0.25$100,000-57.78%
2018-12-21PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
230,769
0.2867%
$0.65$150,000-53.13%
2017-02-23PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
285,714
0.2774%
$0.35$100,000-23.08%
2016-06-06PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Executive Officer
360,000
0.4112%
$0.25$90,000+22.22%
2014-02-19PurchaseCyclo Therapeutics, Inc.
CYTH
director
4.5M
4.4152%
$0.05$225,000+458.33%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.